Insider Transactions in Q4 2021 at Fibrogen Inc (FGEN)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2021
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-1.07%
|
$7,238
$14.97 P/Share
|
|
Dec 06
2021
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,668
-1.23%
|
$37,352
$14.19 P/Share
|
|
Dec 01
2021
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,338
-3.96%
|
$52,056
$12.65 P/Share
|
|
Oct 06
2021
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,859
-1.37%
|
$18,590
$10.2 P/Share
|
|
Oct 04
2021
|
Mark Eisner EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
74,520
+40.49%
|
-
|
|
Oct 04
2021
|
Christine Chung SVP, CHINA OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
54,170
+19.95%
|
-
|